Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

27.34 +0.18 (+0.64%)

Streaming Delayed Price Updated: 11:13 AM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Looking Into Pfizer Inc's Recent Short Interest ↗

November 12, 2025

Via Benzinga

Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering

November 12, 2025

Irvine, CA – November 12, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a significant decline in its stock value today, plummeting by 17.8% in premarket trading. This sharp drop comes on the...

Via MarketMinute

2 Strong Healthcare Stock Picks for Value Investors ↗

November 12, 2025

Value-driven plays abound in the top healthcare stocks.

Via The Motley Fool

Topics Intellectual Property

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

November 12, 2025

From Pfizer Inc.

Via Business Wire

Pfizer CEO Reportedly Drops F-Bomb On Live TV Discussing Seagen, Metsera Deals ↗

November 10, 2025

Via Stocktwits

Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker ↗

November 12, 2025

Novo Nordisk's Coramitug cut NT-proBNP levels and was well tolerated in a Phase 2 ATTR-CM trial, paving the way for its Phase 3 CLEOPATTRA study.

Via Benzinga

Santa Claus Rally: 3 Discounted Stocks Heading Into 2026 ↗

November 12, 2025

Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.

Via Talk Markets

Why Metsera's Share Price Is Plummeting This Week ↗

November 12, 2025

The biotech start-up's stock had been rising rapidly in 2025.

Via The Motley Fool

3 Unprofitable Stocks That Concern Us

November 11, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗

November 11, 2025

Via Stocktwits

1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down

November 11, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India ↗

November 11, 2025

Novo Nordisk shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc.

Via Benzinga

Most active S&P500 stocks in Tuesday's session ↗

November 11, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Curious about the most active stocks on Tuesday? ↗

November 11, 2025

Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

AI Takes Center Stage: LogiPharma Report Reveals Pharmaceutical Supply Chains Embrace Intelligent Automation

November 11, 2025

The pharmaceutical industry, long known for its meticulous processes and stringent regulations, is undergoing a profound transformation driven by Artificial Intelligence. A recent LogiPharma AI Report...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

Where Will Pfizer Be in 3 Years? ↗

November 11, 2025

Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated.

Via The Motley Fool

Topics Intellectual Property

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗

November 11, 2025

Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.

Via The Motley Fool

Shutdown Deal Breathes New Life Into Wall Street ↗

November 11, 2025

The prospect of a quick end to the US government shutdown has rekindled investor confidence. Tech rebounds, semiconductors sprint ahead, and insurers feel political pressure building. Meanwhile, all...

Via Chartmill

Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring ↗

November 11, 2025

Pfizer not only beat expectations last quarter, but also boosted its guidance.

Via The Motley Fool

Topics Earnings Intellectual Property

The Top 5 Analyst Questions From Pfizer’s Q3 Earnings Call

November 11, 2025

Pfizer’s third quarter results reflected ongoing challenges in its COVID-19 franchise, but management pointed to solid growth in non-COVID products and disciplined cost management as key drivers of...

Via StockStory

Topics Earnings

Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds

November 10, 2025

New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Looking for the most active stocks in the S&P500 index on Monday? ↗

November 10, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

These stocks are the most active in today's session ↗

November 10, 2025

Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

Via Chartmill

AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps

November 10, 2025

The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable...

Via TokenRing AI

Topics Artificial Intelligence

Market Resilience Tested: How Investors Can Navigate U.S. Government Shutdowns

November 10, 2025

As the U.S. political landscape continues to present its unique set of challenges, the specter of a government shutdown remains a perennial concern for investors. These periods, marked by a cessation...

Via MarketMinute

Topics Bonds Economy Government

Wall Street Cheers as Senate Vote Signals End to Record-Breaking US Government Impasse

November 10, 2025

Global equity markets have surged in early November 2025, fueled by renewed optimism that the United States government's historic shutdown, which commenced on October 1, 2025, may finally be nearing...

Via MarketMinute

Topics Economy Workforce

Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial ↗

November 10, 2025

Cogent Biosciences stock rises as bezuclastinib plus Sutent shows 50% lower progression risk and strong efficacy in Phase 3 GIST trial.

Via Benzinga

Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion ↗

November 10, 2025

The final bid, at $10 billion, is expected to wrap up after Nov. 13 with the next shareholders' vote.

Via Investor's Business Daily

Topics Initial Public Offering

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.